Reduser bruken av azitromycin som engangsdose

Tidsskrift for den Norske Laegeforening

Volumn 131, Issue 7, 2011, Pages 673-674

  Moi, Harald ^a,b   Vestrheim, Didrik F ^c   Olsen, Anne Olaug ^c  

^a Olafiaklinikken   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Olafiaklinikken ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN;

ANTIBIOTIC RESISTANCE; CHLAMYDIASIS; DOSE RESPONSE; HUMAN; NOTE;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 79954468107     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.10.1224     Document Type: Note

References (16)

1. Smittevern 18: Smittevernboka. Oslo: Folkehelseinstituttet, 2010.
2. Lindbæk M, red. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oslo: Helsedirektoratet, 2008. www.helsebiblioteket.no/microsite/Antibiotikaretningslinjer (22.11.2010).
3. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a metaanalysis of randomized clinical trials. Sex Transm Dis 2002; 29: 497-502.
4. Jensen JS, Bradshaw CS, Tabrizi SN et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47: 1546-53.
5. Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium hos menn med urethritt. Tidsskr Nor Legeforen 2008; 128: 2709-11.
6. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19: 676-9.
7. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12: 1149-52.
8. Björnelius E, Anagrius C, Bojs G et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84: 72-6.
9. Statens seruminstitut. EPI-Nyt. Infektionssygdomme i Grønland, del II. www.ssi.dk/Aktuelt/Nyhedsbreve/EPI-NYT/~/media/Indhold/DK%20-%20dansk/Aktuelt/Nyhedsbreve/EPI-NYT/EPINYT-Arkiv/2003/2003%20pdf/EPI-NYT%20-%202003%20-%20uge%208.ashx (22.11.2010).
10. Liu Y, Ye X, Zhang H et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 2010; 67: 355-8.
11. Baquero F, Baquero-Artigao G, Cantón R et al. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50 (suppl S2): 27-37.
12. Malhotra-Kumar S, Lammens C, Coenen S et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebocontrolled study. Lancet 2007; 369: 482-90.
13. Schwebke JR, Rompalo A, Taylor S et al. Re-evaluating the treatment of nongonococcal urethritis: Emphasizing emerging pathogens - a randomized clinical trial. Clin Infect Dis 2011; 52: 163-70.
14. Jernberg EJ, Moi H. Mycoplasma genitalium - etiologisk agens for seksuelt overført infeksjon. Tidsskr Nor Lægeforen 2007; 127: 2233-5.
15. Mena LA, Mroczkowski TF, Nsuami M et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitaliumpositive urethritis in men. Clin Infect Dis 2009; 48: 1649-54.
16. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a metaanalysis of randomized clinical trials. Sex Transm Dis 2002; 29: 497-502.